Abstract Ryanodine receptor 1 (RyR1) is well-known to be expressed in systemic and pulmonary vascular smooth muscle cells (SMCs); however, its functional roles remain largely unknown. In the present study, we attempted to determine the potential importance of RyR1 in membrane depolarization-, neurotransmitter-, and hypoxia-induced Ca 2+ release and contraction in pulmonary artery SMCs (PASMCs) using RyR1 homozygous and heterozygous gene deletion (RyR1 
Introduction
An increase in [Ca 2+ ] i serves as an important and ubiquitous signal that mediates numerous cellular functions in systemic and pulmonary vascular smooth muscle cells (SMCs). Ca 2+ release from the sarcoplasmic reticulum (SR) through ryanodine receptors/Ca 2+ release channels (RyRs) is likely to be a major route for an increase in [Ca 2+ ] i , which can be manifested in local and global Ca 2+ signaling with distinct spatiotemporal properties.
The functional importance of RyRs has been recognized in cerebral (systemic) artery SMCs where intraluminal pressure may result in extracellular Ca 2+ influx through plasma membrane (plasmalemmal) voltage-dependent Ca 2+ channels (VDCCs), opening of RyRs on the SR membrane, and then local Ca 2+ release events (Ca 2+ sparks), which in turn activates plasmalemmal Ca 2+ -activated K + channels to produce spontaneous transient outward currents (STOCs), leading to membrane hyperpolarization, inhibition of Ca expressed in systemic vascular SMCs, it remains unclear which of these RyR subtypes may mediate the physiological, negative regulation of systemic vascular tone. RyR3 seems unlikely to be a crucial contributor because the activity of RyR-mediated Ca 2+ sparks and attendant STOCs are both increased in cerebral artery SMCs from RyR3 homozygous gene deletion (RyR3 −/− ) mice [2] . Moreover, suppression of RyR3 gene expression by antisense oligonucleotides does not affect membrane depolarization-induced Ca 2+ sparks in cultured rat portal vein myocytes [3] . We and other investigators have recently found that all three RyR subtypes are expressed in rat and mouse pulmonary artery SMCs (PASMCs) [4] [5] [6] . Pharmacological inhibition of RyRs significantly attenuates neurotransmitterand hypoxia-induced increase in [Ca 2+ ] i and contraction in PASMCs. RyR3 homozygous gene deletion diminishes hypoxia-induced, but not neurotransmitter-induced, Ca 2+ and contractile responses [4] . Taken together, these previous findings led us to hypothesize that RyR1 may play an important functional role in PASMCs. 2+ and contractile responses in PASMCs [4, [7] [8] [9] [10] . As such, we wondered whether it might require the involvement of RyR1 by testing the effect of RyR1 gene deletion on neurotransmitter-induced increase in [Ca 2+ ] i in PASMCs and muscle contraction in pulmonary arteries. Our previous study has revealed that RyR antagonists can further inhibit hypoxic responses in RyR3 −/− PASMCs, suggesting the potential role of RyR1 in the hypoxic response [4] . Thus, we finally examined and compared hypoxic increase in [Ca 2+ ] i in RyR1 −/− and RyR1 +/+ PASMCs, as well as muscle contraction in RyR1 +/− and RyR1 +/+ pulmonary arteries.
Materials and methods

Isolated cell preparation
All animal experiments were performed in accordance with the approved Protocol of Animal Use and Care of Albany Medical College. RyR1 −/− mice were generated as reported previously [11] and maintained as heterozygotes. To obtain RyR1 −/− mice and their matching RyR1 +/+ controls, RyR1
+/− animals were breed as timed pregnancy. Mice at 17 days of gestation were euthanized by an intraperitoneal injection of sodium pentobarbital (150 mg/kg). RyR1
, and RyR1 +/+ mice were identified using tail DNA genotyping [11] . Pulmonary arteries were removed from embryonic RyR1 +/+ and RyR1 −/− mice and placed in ice-cold physiological saline solution (PSS) containing (in mM) 125 NaCl, 5 KCl, 1 MgSO 4 , 10 HEPES, 1.8 CaCl 2 , and 10 glucose (pH 7.4). Blood vessels were cut into small pieces (1× 10 mm), and then digested using the two-step enzymatic method [4] . Arteries were initially incubated in low (100 μM) Ca 2+ PSS containing 0.5 mg/ml papain at 37°C for 10-15 min, followed by incubation in low Ca 2+ PSS containing 0.4 mg/ml type F and 0.5 mg/ml type II collagenase for 10-15 min. Single cells from fully digested arteries were harvested by gentle trituration, placed in DMEM containing 1% fetal bovine serum albumin (BSA) and 100 μM bromodeoxyuridine to inhibit fibroblast growth in a humidified incubator with 5% CO 2 at 37°C, and used for experiments within 2 days.
In some experiments, RyR1 +/− and matching RyR1 +/+ mice at age of 8-10 weeks (adult) were used. The third and smaller branches of the pulmonary arteries were taken from these mice and then digested using the same procedure as described above, except that the concentration of papain, type F collagenase, and type II collagenase were increased to 1.0, 0.8, and 1.0 mg/ml, respectively. Freshly isolated PASMCs were kept on ice for daily use.
Immunofluorescence staining
Immunofluorescence staining was performed, as we described before [4] . Cells were fixed in 4% paraformaldehyde in PSS for 20 min at room temperature, incubated with 0.2% Triton X-100 in PSS for 30 min, and then blocked for 1 h with 2.5% BSA PSS. After that, cells were incubated with monoclonal anti-RyR1 antibody (1:100 dilution; Upstate Biotechnology, Lake Placid, NY, USA) overnight at 4°C, followed by Alexa 488-conjugated antibody (1:500; Molecular Probes, Eugene, OR, USA) for 2 h. Immunofluorescence staining was examined using a Zeiss LSM510 laser-scanning confocal microscope. The confocal pinhole was set to provide a spatial resolution of 1 μm in the x-y axis. The z interval was adjusted to 1 μm to obtain sufficient fluorescence signals. Alexa Fluor 488 was excited at 488 nm using a kryptonargon laser, and the emitted fluorescence at 510 nm was detected. To minimize the potential effects of the variations in sample processing and image acquisition on the recorded fluorescent signals, we carefully and concurrently prepared RyR1
+/− , and their matching RyR1 +/+ mouse PASMCs and took fluorescence images.
Measurement of Ca
2+ sparks
Single PASMCs were loaded with 5 μM fluo-4/AM in normal Ca 2+ (1.8 mM) PSS for 30 min and then were superfused for 10 min. The dye was excited with 488 nm, and the emitted fluorescence was measured at 505 nm. To obtain high temporal profiles of Ca 2+ sparks, line-scan images were acquired using a Leica TCS SP2 laserscanning confocal microscope (Leica, Mannheim, Germany) with a Leica ×40 oil immersion objective (NA 1.3), as reported previously [6, 8, 12] . The recording time was set at 5 s to obtain a number of Ca 2+ sparks and minimize laser toxicity. Spatiotemporal characteristics of Ca 2+ sparks were analyzed using the Leica Image Examiner and Interactive Data Language software (Research Systems, Boulder, CO, USA).
Measurements of whole-cell [Ca 2+ ] i
Whole-cell [Ca 2+ ] i was measured using a dual-excitation wavelength fluorescence method with a TILL fluorescence imaging system (TILL Photonics, Gräfelfing, Germany) and a Nikon ×20 oil immersion objective, as described previously [4] . PASMCs were loaded with 5 μM fura-2/ AM in PSS for 30 min. The dye was excited alternatively at 340 and 380 nm wavelength (Xenon 75 W arc lamp), and the emission fluorescence was detected at 510 nm. Background fluorescence was determined by measuring an adjacent noncell region of the field. [ concentrations were determined using nominally Ca 2+ -free PSS containing 10 mM ionomycin and 10 mM ethylene glycol bis(2-aminoethyl ether)-N,N,N′,N′-tetraacetic acid (EGTA) and PSS containing 10 mM ionomycin and 10 mM Ca 2+ , respectively.
Patch clamp recordings
Voltage-dependent Ca 2+ currents (I Ca ) were recorded using the nystatin-perforated patch clamp recordings with the EPC-9 patch clamp system (HEKA Electronics, Lambrecht, Germany), as described previously [4] . Nystatin was included in the pipette solution at a final concentration of 300 μg/ml. Patch pipettes had a resistance of 3-4 MΩ. Junction potentials between the pipette and bath solutions were compensated just before seal formation. 
Measurement of muscle tension
The third branches of the pulmonary arteries from adult RyR1 +/− and RyR1 +/+ mice were sliced into rings of 1.5-mm length and placed in 2-ml tissue baths (Radnoti, Monrovia, CA, USA). One end of the vessel segments was fixed to a clip, and the other end was connected to a highly sensitive force transducer (Harvard Apparatus, Holliston, MA, USA). Bath solution contained (in mM) 110 NaCl, 3.4 KCl, 2.4 CaCl 2 , 0.8 MgSO 4 , 25.8 NaHCO 3 , 1.2 KH 2 PO 4 , and 5.6 glucose (pH 7.4); was aerated with 20% O 2 , 5% CO 2 , and 75% N 2 ; and warmed at 37°C. Pulmonary artery rings were set at a resting tone of 200 mg. Muscle tension was recorded using a PowerLab/4SP recording system (AD Instruments, Colorado Springs, CO, USA).
Reagents
Fura-2/AM and Fluo-4/AM were purchased from Molecular Probes. Fura-2 (pentapotassium salt) and caffeine were obtained from Calbiochem (La Jolla, CA, USA). All other chemicals used in this study were purchased from Sigma (St Louis, MO, USA).
Data analysis
All values were expressed as the means±SEM of n cells or tissues investigated. Student's t test was used to determine the significance of differences, and a P value of <0.05 was considered to be statistically significant.
Results
The activity of spontaneous Ca 2+ sparks is significantly reduced in RyR1 −/− mouse PASMCs
Considering that the functional role of RyR1 is unclear in vascular SMCs, we first investigated whether RyR-mediated Ca 2+ sparks were altered in isolated PASMCs from embryonic RyR1 −/− mice. As shown in Fig. 1 As the functional activity of targeted molecules can be significantly inhibited in heterozygous gene deletion animals, we tested whether caffeine-induced global Ca 2+ release was also reduced in isolated PASMCs from adult RyR1 +/− mice using a TILL fluorescence imaging system. Fig. 5a ) and 260.3±34.0 nM in embryonic (Fig. 9a) . However, ATP (30 μM)-caused response was not different between embryonic (Fig. 8a) and adult RyR1 +/+ cells (Fig. 9a) (Fig. 9b) . Moreover, muscle contraction evoked by the adrenergic receptor neurotransmitter norepinephrine (300 μM) was significantly reduced as well in RyR1 +/− mouse pulmonary arteries (Fig. 9c) . The mean muscle tension elicited by norepinephrine was decreased from 90.8±15.7 mg in RyR1 +/+ pulmonary arteries (n=12 from six mice) to 34.0± 6.6 mg in RyR1 +/− pulmonary arteries (n=14 from seven mice; P<0.05). [4, 6, 13] . As shown in Fig. 10a, hypoxic Fig. 10a ).
To further test the contribution of RyR1 to hypoxic responses, we examined and compared hypoxia-induced vasoconstriction in adult RyR1 +/+ and RyR1 +/− mouse pulmonary arteries. As shown in Fig. 10b , hypoxic vasoconstriction was much smaller in RyR1 +/− pulmonary arteries relative to RyR1 +/+ pulmonary arteries. The mean hypoxic vasoconstriction was, respectively, 68.9±8.6 mg in RyR1 +/+ pulmonary arteries (n=8 from four mice) and 36.4±6.9 mg in RyR1 +/− pulmonary arteries (n=8 from four mice; P<0.05).
Discussion
Ca 2+ sparks due to the opening of multiple RyRs have been detected in a variety of cell types including systemic and pulmonary vascular smooth muscle cells using a laser- (Fig. 1) . As Ca 2+ spark frequency and amplitude are both predominantly controlled by the number of functional RyRs, the distinct effects of RyR1 gene deletion on these two properties suggest that these Ca 2+ release channels may generate Ca 2+ sparks on their own. Alternately, RyR1 may form a local Ca 2+ release unit with RyR2 and/or RyR3; as such, RyR1 is likely to be obligatory for the operation of the mixed functional units. It might also be envisaged that RyR1 gene deletion could upregulate RyR2 and/or RyR3 expression through an unknown compensatory process by which the amplitude of Ca 2+ sparks might remain unchanged. However, this is an unlikely case because a very recent study has shown that there is no significant change in RyR2 and RyR3 expression in RyR1 −/− mouse bladder SMCs [15] . In addition, we have found that the resting level of [Ca 2+ ] i is equivalent in RyR1 +/+ and RyR1 −/− PASMCs. Consistent with our finding that the activity of Ca 2+ sparks is greatly suppressed in PASMCs, it has been reported that suppression of RyR1 expression using antisense oligonucleotides inhibits depolarization-induced Ca 2+ sparks in cultured rat portal vein myocytes [3] . In addition, RyR1 gene deletion has been found to abolish depolarization-induced Ca 2+ sparks in mouse bladder SMCs [15] . Taken together, these data indicate that RyR1 is important for the generation of Ca 2+ sparks in pulmonary artery and other types of SMCs. It is conceivably believed that RyR2 participates in the generation of Ca 2+ sparks in vascular SMCs. Indeed, Coussin et al. have reported that antisense oligonucleotides-mediated inhibition of RyR2 expression blocks depolarization-evoked Ca 2+ sparks in cultured portal vein SMCs [3] . The activity of Ca 2+ sparks is significantly increased in FKBP12.6 −/− mouse bladder myocytes [16] . This result, together with the previous findings that FKBP12.6 physiologically binds to and inhibits RyR2 in systemic and pulmonary artery SMCs [13, 17] , further suggests the contribution of RyR2 to the generation of Ca 2+ sparks in vascular myocytes. Moreover, a recent study has found that the frequency and amplitude of Ca 2+ sparks are reduced in bladder SMCs from RyR2 +/− mice [18] . As for the role of RyR3 in the formation of Ca 2+ sparks in vascular SMCs, experimental data are inconsistent. RyR3 gene deletion increases the activity of Ca 2+ sparks in mouse cerebral artery myocytes [2] , while RyR3 gene suppression has no effect on depolarization-induced Ca 2+ sparks in rat portal vein SMCs [3] . The activity of Ca 2+ sparks is unaltered as well in RyR3 −/− mouse bladder SMCs [16] . As such, it is worthwhile to perform additional studies to determine the role of RyR2 and RyR3 in the generation of Ca 2+ sparks in PASMCs.
We and other investigators have previously described spontaneous Ca 2+ sparks in adult rat and mouse PASMCs [6, 8, 14] . Compared with adult mouse PASMCs [6] [19] . This CICR via the "loose coupling mechanism" in bladder myocytes has been suggested to be mediated by RyR2, as it is significantly promoted by FKBP12.6 gene deletion and not affected by RyR3 gene deletion [16] . Supportedly, depolarization-induced Ca 2+ sparks and waves are reduced in adult RyR2 +/− mouse bladder SMCs [18] . Our current findings that RyR1 mediates Ca 2+ release from the SR and associated contraction following membrane depolarization through its direct coupling to VDCCs provide an additional mechanism for excitation-contraction coupling in SMCs. In agreement with this concept, membrane depolarization-induced Ca 2+ sparks are abolished in embryonic RyR1
−/− mouse bladder myocytes [15] . Moreover, a previous study using antisense oligonucleotides indicate that RyR1 is involved in CICR in cultured portal vein myocytes [3] . Previous studies from our laboratory and others have shown that Ca 2+ release from the SR through IP 3 Rs in response to neurotransmitters or other agonists can activate RyRs via a local CICR process to induce further SR Ca 2+ release, amplifying neurotransmitter-or agonist-evoked Ca 2+ release and attendant contraction in pulmonary vascular SMCs [4, 7, 9, 10, 20] . Similar pharmacological evidence for RyR-mediated amplification of neurotransmitter-or agonist-induced Ca 2+ response has also been obtained in systemic vascular myocytes and other type of SMCs as well [21] [22] [23] . We have previously found that neurotransmitterinduced increase in [Ca 2+ ] i and contraction are both similar in RyR3 +/+ and RyR3 −/− mouse PASMCs [4] , indicating that this Ca 2+ release channel is not involved in the local CICR process due to the interaction of IP 3 Rs and RyRs. In the present study, we have unveiled that the application of ATP to stimulate purinergic receptors elicits a smaller increase in [Ca 2+ ] i in RyR1 −/− than in RyR1 +/+ PASMCs in the presence and absence of extracellular Ca 2+ (Fig. 8) (Fig. 9) . Collectively, these novel findings greatly extend previous pharmacological studies, indicating that RyR1 is a unique and important contributor to neurotransmitter-induced Ca 2+ and contractile responses in pulmonary and also possibly systemic vascular myocytes.
Relative +/− PASMCs. In the current study, we have also shown that hypoxic muscle contraction in isolated pulmonary arteries is significantly attenuated in RyR1 +/− mice relative to RyR1 +/+ mice (Fig. 10) . Together, these data indicate that RyR1, similar to RyR3, is important for hypoxia-mediated increase in [Ca 2+ ] i and contraction in PASMCs.
In conclusion, our findings provide evidence for the important functions of RyR1 as an essential molecular component of RyRs contributing to spontaneous local Ca 2+ release, as well as membrane depolarization-, neurotransmitter-, and hypoxia-induced global Ca 2+ release and attendant contraction in vascular (pulmonary artery) SMCs.
